EpiPen is drug manufacturer Mylan’s best known product for not only its prominence in the pharmaceutical market, but the controversy surrounding the dramatic price increases over the years. In 2009, the wholesale price of two EpiPens was about $100. By May of 2016, the price rose approximately 500 percent to $609.
The manufacturer of the disposable, pre-filled injector that administers epinephrine to counteract allergic reactions faced a public relations firestorm over the cost jump. Their practices also launched a nationwide debate over soaring drug costs at Mylan and throughout the industry.